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Abstract
AIM: To study statements and recommendations on 
psychosocial issues as presented in international evi-
dence-based guidelines on the management of inflam-
matory bowel diseases (IBD). 
METHODS: MEDLINE, guidelines International Net-
work, National Guideline Clearing House and National 
Institute for Health and Care Excellence were searched 
from January 2006 to June 30, 2013 for evidence-
based guidelines on the management of IBD.
RESULTS: The search yielded 364 hits. Thirteen guide-
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prepared in Asia, eight in Europe and two in the United 
States. Eleven guidelines made statements and rec-
ommendations on psychosocial issues. The guidelines 
were concordant in that mental health disorders and 
stress do not contribute to the aetiology of IBD, but 
that they can influence its course. It was recommended 
that IBD-patients should be screened for psychological 
distress. If indicated, psychotherapy and/or psycho-
pharmacological therapy should be recommended. IBD-
centres should collaborate with mental health care spe-
cialists. Tobacco smoking patients with Crohn’s disease 
should be advised to quit.
CONCLUSION: Patients and mental health special-
ists should be able to participate in future guideline 
groups to contribute to establishing recommendations 
on psychosocial issues in IBD. Future guidelines should 
acknowledge the presence of psychosocial problems in 
IBD-patients and encourage screening for psychological 
distress.
© 2014 Baishideng Publishing Group Co., Limited. All rights 
reserved.
Key words: Anxiety; Depression; Guidelines; Inflam-
matory bowel diseases; Psychological; Psychotherapy; 
Smoking; Stress
Core tip: A search of the literature found 13 evidence-
based guidelines on the management of inflammatory 
bowel diseases (IBD). Three guidelines were prepared 
in Asia, eight in Europe and two in the United States. 
Mental health care specialists participated in estab-
lishing six guidelines and representatives of patient 
support  groups participated in establishing seven 
guidelines. Eleven guidelines made statements and 
recommendations on psychosocial issues. The guide-
lines were concordant in that mental health disorders 
and stress do not contribute to the aetiology of IBD, 
but they can influence its course. IBD-patients should 
be screened for psychological distress. If indicated, 
review aims to assess the role of  psychosocial issues in 
the course of  IBD and explore the recommendations on 
the diagnosis and treatment of  psychosocial problems 
as presented in the recent international evidence-based 
guidelines on the management of  IBD.
MATERIALS AND METHODS
Protocol
Methods of  the analysis and the inclusion criteria for the 
present study were specified in advance. The review fol-
lowed the recommendations of  the Cochrane Collabora-
tion for systematic reviews of  systematic reviews[13].
Eligibility criteria
Types of  guidelines: We selected evidence-based 
guidelines on the management of  IBD (UC and/or CD) 
which included: (1) a systematic search and analysis of  
the literature; and (2) a structured consensus (informal 
and/or Delphi process and/or consensus development 
conference and/or nominal group technique) to build 
recommendations. 
We excluded evidence-based guidelines which: (1) 
focussed on single diagnostic (e.g., screening for colorec-
tal cancer) or therapeutic procedures (e.g., biologicals) or 
special situations (e.g., severe ulcerative colitis); and (2) 
were only based on expert consensus and/or a narrative 
search of  the literature.
Types of  outcome measures: We included any state-
ments and recommendations on psychosocial issues in 
IBD. The following psychosocial issues were considered 
to be relevant: psychological distress (anxiety, depression), 
stress (daily hassles, major life events), coping, health-
related quality of  life, psychological diagnostics, psycho-
logical therapies, psychotherapy, psychopharmacological 
therapies. We assessed whether the evidence level (EL) 
of  statements or recommendations was reported by the 
guidelines.
Data sources and searches 
The electronic bibliographic databases screened included 
MEDLINE, guidelines International Network, National 
Guideline Clearing House and National Institute for 
Health and Care Excellence (NICE) from January 2006 
to June 30, 2013. We did not search for guidelines pub-
lished before 2006, because evidence-based guidelines 
need to be updated regularly and this review was con-
cerned with the most up-to-date evidence. The search 
strategy for MEDLINE followed the recommendation 
of  the Association of  the Medical Scientific Societies in 
Germany to identify evidence-based guidelines[14]. The 
search strategy for PubMed is outlined in Table 1. The 
search strategy was adapted for each database if  neces-
sary. No language restrictions were made. In addition, 
reference sections of  evidence-based guidelines on the 
management of  IBD were screened manually. 
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psychotherapy and/or psychopharmacological therapy 
should be recommended. 
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INTRODUCTION
Psychosocial issues are a significant dimension of  inflam-
matory bowel diseases (IBD), chronic conditions of  the gas-
trointestinal tract with an unknown aetiology and unpredict-
able course. Two main subtypes of  IBD are Crohn’s disease 
(CD) and ulcerative colitis (UC). A systematic review of  
qualitative studies exploring the phenomenon of  living 
with IBD demonstrated a highly negative impact of  the 
disease on the overall quality of  life[1]. In the European 
Federation of  Crohn’s and Ulcerative Colitis Associations 
(EFCCA) patient survey (n = 5576 participants), 75% of  
patients reported that symptoms affected their ability to 
enjoy leisure activities and 69% felt that symptoms af-
fected their ability to perform at work[2]. In a survey of  
the French association of  IBD patients (n = 1663), 12% 
of  IBD patients reported depression and 41% reported 
anxiety[3]. Other studies reported that as many as 75% 
of  IBD patients believe that stress is a major contribu-
tor to the development of  their disease and up to 90% 
of  patients believe that stress triggers flares of  their dis-
ease[4-6]. In the recent study, 30% of  patients (of  n = 302) 
expressed the need for psychological interventions[7] while 
in another paper it was demonstrated that 60% of  IBD 
patients did not receive adequate help for their psycho-
logical problems[8].
The importance of  psychosocial issues as perceived 
by individual patients is also supported by cohort studies 
with IBD populations. There is a strong evidence for the 
high comorbidity of  anxiety and depression with IBD, 
indicating also that the symptoms of  these mental health 
conditions are more severe during periods of  active IBD 
and that the course of  the disease worsens in depressed 
patients[9]. Health-related quality life in IBD-patients is 
not only negatively affected by disease activity but also by 
depression[10] and psychological distress has been found 
to be associated with non-adherence to medical treat-
ment[11]. A recent systematic review demonstrated that 13 
of  18 prospective studies reported significant relation-
ships between stress and adverse outcomes in IBD[12].
Evidence-based guidelines gain growing recognition 
in providing patients and physicians with recommenda-
tions on diagnosis and treatment of  the most frequent 
clinical situations based on the best available knowledge. 
Given the importance of  psychosocial issues in IBD for 
the disease prognosis and management, this systematic 
Guidelines selection
Two authors independently screened the titles and ab-
stracts of  potentially eligible studies identified by the 
search strategy detailed above (WH, AMW). The full 
text articles were then examined independently by two 
authors to determine if  they met the inclusion criteria 
(WH, AMW). Discrepancies were rechecked and con-
sensus achieved by discussion. If  needed, a third author 
reviewed the data to reach a consensus (GM). 
Data collection process
Two authors independently extracted the data using 
standard extraction forms (WH, AMW). Discrepancies 
were rechecked and consensus achieved by discussion. If  
needed, a third author reviewed the data to reach a con-
sensus (GM).
RESULTS
The search of  the literature yielded 364 hits. One hit 
(guideline of  the Finnish Society of  Gastroenterology) 
was not available by libraries or the website of  the Finn-
ish Society of  Gastroenterology. Thirteen guidelines were 
included into the review after screening of  full papers 
(Figure 1). Three guidelines were prepared in Asia, eight 
in Europe and two in the United States. Three guidelines 
were on IBD and five each on UC and CD. The compo-
sition of  the guidelines groups are outlined in Table 2. 
The methods used in the guideline process are outlined 
in Table 3.
We present the statements and recommendations of  
the guidelines in the chronological order.
NICE guidelines on UC published in 2013 gave two 
recommendations on information provided to patients 
which should include impact of  IBD on sexual functions, 
lifestyle, psychological wellbeing and sources of  support 
and advice to be given before and after surgery (no EL 
reported). The NICE guidelines did not comment on 
psychological therapies in the summary of  the topics 
which the guideline does not cover[15].
European Crohn’s Colitis Organization (ECCO) guide-
lines on UC published in 2013 included three statements 
on the impact of  psychosocial factors on the disease, three 
recommendations on psychosocial diagnostics and two 
statements on psychological treatment (Table 4)[16].
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Table 1  Search strategy used for PubMed
To locate guidelines
   1 "Practice guidelines as topic"[MESH]
   2 "Practice guideline"[Publication type]
   3 "Consensus development conferences as topic"[MESH]
   4 "Consensus development conferences, NIH as topic"[MESH]
   5 "Consensus development conference, NIH "[Publication type]
   6 "Consensus development conference "[Publication type]
   7 or 1-6
To locate IBD
   8 “Inflammatory bowel disease [MESH]”
   9 “Colitis, ulcerative [MESH]”
   10 “Crohn Disease [MESH]”
   11 or 8-9
   12, 7 and 11
IBD: Inflammatory bowel diseases.
Figure 1  Preferred reporting items for systematic reviews and meta-analyses flow diagram. G-I-N: Guidelines International Network; NGC: National Guideline 
Clearing House; NICE: National Institute for Health and Care Excellence.
Häuser W et al . Psychosocial issues in IBD-guidelines
Records identified through 
database searching






identified through other 
sources
(n  = 0)
Records after duplicates removed
(n  = 150)
Records screened
(n  = 150)
Full-text articles assessed for eligibility
(n  = 13)
Studies included in qualitative synthesis
(n  =13)
Records excluded
(n  = 137)
Full-text articles excluded, with reasons





















3666 April 7, 2014|Volume 20|Issue 13|WJG|www.wjgnet.com
the impact of  psychosocial factors on the disease, three 
recommendations on psychosocial diagnostics and two 
statements on psychological treatment (Table 6)[20].
The Asia-Pacific consensus statements on UC pub-
lished in 2010 did not include any statement or recom-
mendations on psychosocial issues[21].
The American College of  Gastroenterology ulcerative 
colitis practice guidelines published in 2010 did not in-
clude any statements or recommendations on psychoso-
cial issues[22].
The Dutch practice guidelines on Diagnostics and 
treatment of  inflammatory bowel diseases for adults 
published in 2010 gave three statements on the impact of  
psychosocial factors on the disease and five statements 
on psychological treatment (Table 7)[23].
ECCO guidelines on CD published in 2010 included 
three statements on the impact of  psychosocial factors 
on the disease, three recommendations on psychosocial 
diagnostics and two statements on psychological treat-
ment (Table 8)[24].
The American College of  Gastroenterology Crohn’s 
disease practice guidelines published in 2009 included 
one statement on psychosocial issues: Although many 
patients (and family members) are convinced that stress 
is an important factor in the onset or course of  illness, 
it has not been possible to correlate the development of  
disease with any psychological predisposition to or exac-
erbations of  stressful life events. No levels of  evidence 
were reported for this statement[25].
The German Society of  Gastroenterology guidelines 
on CD published in 2008 included three statements on 
the impact of  psychosocial factors on the disease, three 
recommendations on psychosocial diagnostics and three 
statements on psychological treatment (Table 9)[26].
The Japanese guidelines on CD published in 2013 
made one statement on HRQOL and gave three recom-
mendations on life style modification: (1) in the active 
phase of  the disease, patients face restrictions of  social 
activities, such as school or work, due to treatment or 
hospitalization (no EL reported); (2) upon diagnosis, the 
patient with CD should quit smoking (EL3); (3) patients 
should be advised to avoid irregular lifestyle and eating 
habits, and to refrain from excessive alcohol drinking (no 
EL reported); and (4) patients should be advised to adopt 
a lifestyle without excessive mental stress, to have as little 
stress as possible (no EL reported)[17].
NICE guidelines on CD published in 2012 gave two 
recommendations on treatment decisions including psy-
chosocial issues. If  appropriate, age-appropriate multidis-
ciplinary (gastroenterologist, surgeon, IBD-nurse special-
ist) support to deal with any concerns about the disease 
and its treatment, including concerns about body image, 
living with a chronic illness, and attending school and 
higher education should be offered. If  appropriate, infor-
mation, advice and support in line with published NICE 
guidance on smoking cessation and patient experience 
should be given. No levels of  evidence were reported for 
these recommendations. The guidelines did mention psy-
chological therapies in the summary of  the topics which 
the guideline does not cover. However, mental health 
specialists were not mentioned in the context of  the mul-
tidisciplinary team[18].
British Society of  Gastroenterology Guidelines for 
the management of  inflammatory bowel disease in adults 
published in 2011 included two statements and three rec-
ommendations on psychosocial issues (Table 5)[19].
The German Society of  Gastroenterology guidelines 
on UC published in 2011 included three statements on 
Table 2  Overview of the methods of guidelines on the management of inflammatory bowel diseases: composition of guideline panel
Organization Country/continent Year Type of IBD Guideline group (number of persons, specialties)
Asia Pacific Working Group on 
inflammatory bowel diseases
Asia 2013 IBD Number not reported: Gastroenterologist, pathologist, colorectal 
surgeon, pharmacist, nurse, patient support group representative
NICE United Kingdom 2013 UC 13: Gastroenterologist, surgeon, pharmacist, nurse, general practitio-
ner, psychiatrist, patient support group representative
ECCO Europe 2013 UC 35: Gastroenterologist, surgeon, psychosomatic medicine
Japanese Society of Gastroenterology Japan 2013 CD 18: Gastroenterologist, surgeon, general internal medicine
NICE United Kingdom 2012 CD 19: Gastroenterologist, colorectal surgeon, pharmacist, nurse, dieti-
cian, health economist, patient support group representative
British Society of Gastroenterology United Kingdom 2011 IBD 11: Gastroenterologist, surgeon, pediatrist
Asia Pacific Working Group on IBD Asia and Australia 2010 UC 28: Gastroenterologist, colorectal surgeon, pathologist, pharmacist, 
nurse practitioners, patient support group representatives
German Society of Gastroenterology Germany 2011 UC 71: Gastroenterologist, colorectal surgeon, pathologist, dietician, 
psychosomatic medicine, patient support group representative
Dutch Society for Gastroenteroolgy 2010 Number not reported: Gastroenterologist, general practitioners, 
psychologist, internist, dietician, pharmacist, occupational medicine, 
surgery, gynecologist, pathologist, radiologist, nurses, patients 
American College of Gastroenterology USA 2010 UC No detailed information
American College of Gastroenterology USA 2010 CD 30: No detailed information
German Society of Gastroenterology Germany 2011 CD 49: Gastroenterologist, colorectal surgeon, pathologist, dietician, 
psychosomatic medicine, patient support group representative
ECCO Europe 2007 CD 25: Gastroenterologist, surgeon, psychosomatic medicine
IBD: Inflammatory bowel diseases; ECCO: European Crohn’s Colitis Organization; NICE: National Institute for Health and Care Excellence; CD: Crohn’s 
disease; UC: Ulcerative colitis.
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Table 4  European Crohn’s Colitis Organization guideline statements and recommendations on psychosocial issues in ulcerative 
colitis[15]
1 There is no conclusive evidence for anxiety, depression and psychosocial stress contributing to risk for UC onset (EL2)
2 Psychological factors may have an impact on the course of UC. Perceived psychological stress (EL2) and depression (EL2) are risk factors for relapse of 
the disease. Depression is associated with low health-related quality of life (EL3). Anxiety is associated with non adherence with treatment (EL4)
3 Psychological distress and mental disorder are more common in patients with active ulcerative colitis than in population-based controls, but not in pa-
tients in remission (EL3)
4 Clinicians should particularly assess depression among their patients with active disease and those with abdominal pain in remission (EL2)
5 The psychosocial consequences and health- related quality of life of patients should be taken into account in clinical practice at regular visits (EL3). Pa-
tients' disease control can be improved by combining selfmanagement and patient-centred consultations (EL1b)
6 Physicians should screen patients for anxiety, depression and need for additional psychological care and recommend psychotherapy if indicated (EL2). 
Patients should be informed of the existence of patient associations (EL 5)
7 Psychotherapeutic interventions are indicated for psychological disorders and low quality of life (EL1)
8 The choice of psychotherapeutic method depends on the psychological disturbance and should best be made by specialists (Psychotherapist, Specialist 
for Psychosomatic Medicine, Psychiatrist). Psychopharmaceuticals should be prescribed for defined indications (EL5)
UC: Ulcerative colitis; EL: Evidence level.
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Year Type of IBD Databases used Searches until Type of consensus
Asia Pacific 
Working Group on 
inflammatory bowel 
diseases
Asia 2013 IBD English language publications 
in MEDLINE, EMBASE and the 
Cochrane Trials
Register in human subjects. All 
national and international guidelines 
on Ulcerative Colitis were solicited
Not reported Modified Delphi process
Canadian task force
Grade A-E





the quality of evidence
Evidence tables
Formal consensus
ECCO Europe 2013 UC Medline, Central December, 2010 Delphi process and 
structured consensus
Japanese Society of 
Gastroenterology
Japan 2013 CD MEDLINE, the Cochrane Library, 
and the Japan Medical Abstracts 
Society
Up to 2007 Delphi process and 
structured consensus
NICE United Kingdom 2012 CD MEDLINE, Embase, Cinahl and The 
Cochrane Library
13th March 2012 Meta-analyses, grading 
the quality of evidence
Evidence tables
Formal consensus
British Society of 
Gastroenterology
United Kingdom 2011 IBD PubMed, Medline and the Cochrane 
database
No details reported Informal committee 
consensus
German Society of 
Gastroenterology
Germany 2011 UC Medline, Central, PsycInfo Until May 2009 Structured consensus 
process




2010 UC English language publications 
in MEDLINE, EMBASE and 
the Cochrane Trials Register in 
human subjects. All national 
and international guidelines on 
Ulcerative Colitis were solicited
No details reported Modified Delphi process
Dutch Society for 
Gastroenterology
2010 Central, Medline, PsychInfo 2007 Modified Delphi process
American College of 
Gastroenterology
United States 2010 UC Medline No details reported Informal consensus
American College of 
Gastroenterology
United States 2010 CD Medline No details reported Informal consensus
German Society of 
Gastroenterology
Germany 2011 CD Medline, Central, PsycInfo Until April  2007 Structured consensus 
process
ECCO Europe 2007 CD Medline, Central No details reported Delphi process and 
structured consensus
IBD: Inflammatory bowel diseases; ECCO: European Crohn’s Colitis Organization; NICE: National Institute for Health and Care Excellence; CD: Crohn’s 
disease; UC: Ulcerative colitis.
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Table 7  Summary of the dutch national practice guidelines on the management of inflammatory bowel diseases[23]
1 Personality traits do not contribute to the aetiology of IBD1
2 Psychosocial factors such as stress, depression/anxiety and coping have an impact on the course of IBD1
3 Health-related quality of life is influenced by disease activity but also by stress, anxiety/depression, social support and quality of treatment1
4 A positive relationship between patients and health care professionals characterized by mutual respect, communication, education and emotional 
support for patients and families is recommended1
5 Psychosocial problems associated with the disease should be treated by psychological interventions, e.g., stress management training, self-
empowerment, cognitive-behavioural therapy1
6 Anxiety and depression should be treated according to appropriate guidelines
7 IBD-patients who smoke should be advised to quit smoking1
1No level of evidence reported. IBD: Inflammatory bowel diseases.
Table 8  European crohn’s colitis organization guideline statements and recommendations on psychosocial issues in Crohn’s 
disease[24]
1 Psychological disturbances seem to be a consequence of the illness rather than the cause or specific to Crohn’s disease (EL1). The degree of 
psychological distress correlates with the disease severity (EL2) 
2 An association between psychological factors and the aetiology of Crohn’s disease is unproven (EL3), but there is a moderate influence on the course of 
the disease (EL1)
3 Depression and perceived chronic distress seem to represent further risk factors for relapse of the disease (EL1). It remains unclear whether acute life 
events trigger relapses (EL1). Most patients consider stress to have an influence on their illness (EL2)
4 Physicians should assess the patient’s psychosocial status and request additional psychological care and psychotherapy if indicated. Integrated 
psychosomatic care should be provided in IBD centres (EL2)
5 Patients should be informed of the existence of patient associations (EL5)
6 The psychosocial consequences and health related quality of life of patients should be taken into account in clinical practice at regular visits (EL1)
7 Psychotherapeutic interventions are indicated for psychological disorders, such as depression, anxiety, reduced quality of life with psychological 
distress, as well as maladaptive coping with the illness (EL1)
8 The choice of psychotherapeutic method depends on the psychological disturbance and should best be made by specialists (psychotherapist, specialist 
in psychosomatic medicine, psychiatrist). Psycho-pharmaceuticals should be prescribed for defined indications (EL5)
EL: Evidence level; IBD: Inflammatory bowel diseases.
Table 5  British society of gastroenterology guidelines for the management of inflammatory bowel disease in adults[19]
1 The essential supporting services to which the IBD team should have access should include a psychologist/counsellor (no EL reported)
2 Stress and adverse life events do not appear to trigger the onset of Crohn’s disease or ulcerative colitis, but most reports indicate that they may be in-
volved in triggering relapse of IBD. Furthermore, behaviour limiting exposure to stressful situations is associated with reduced symptomatic relapse, at 
least in Crohn’s disease (no EL reported)
3 Evidence indicates that psychosocial support is useful, particularly in adolescents. There is no definitive evidence that psychological interventions im-
prove the course of IBD itself but they do usually improve patients’ quality of life and wellbeing (no EL reported)
4 Psychological support should be available to patients with IBD (no EL reported)
IBD: Inflammatory bowel diseases; EL: Evidence level.
Table 6  German guideline guideline statements and recommendations on psychosocial issues in the management of ulcerative 
colitis[20]
1 Adverse life events, psychological stress and mental health disorders are not aetiologically linked to the onset of UC (EL2)
2 Subjective stress and affective disorders may have a negative impact on the course of UC
3 High disease activity is associated with high psychological symptom burden EL2)
4 Mental health disorders have a negative impact on the course of the disease and quality of life EL2)
5 Patients with persistent abdominal pain or diarrhea which cannot be explained by disease activity or complications of the disease should be assessed 
for irritable bowel syndrome (IBS) or depressive disorder. If IBS or depressive disorder is diagnosed, these disorders should be treated according to 
guideline recommendations (EL2)
6 Psychosocial co-morbidities and health- related quality of life (accounting for gender differences) should be taken into account in clinical practice at 
regular visits (EL2)
7 Care should involve cooperations with specialists in psychotherapy or psychosomatic medicine (EL2)
8 Physicians should inform patients about IBD self-help organisations (EL5)
9 In the case of a mental health disorder, psychotherapy is recommended (EL2)
10 Psychosocial support should be offered to children and adolescents (EL1)
UC: Ulcerative colitis; EL: Evidence level.
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DISCUSSION
There is a growing body of  evidence demonstrating the 
role of  stress, anxiety and depression in IBD presentation 
and progression[9,12,27,28]. Evidence-based guidelines are 
increasingly becoming the major source of  recommen-
dations on diagnosis and treatment not only in IBD but 
also in other conditions and that is why it is important 
that problems of  clinical significance (such as the role 
of  psychosocial issues in IBD management) are included 
and commented on in the guidelines. This is the first 
review which has summarised current guidelines on the 
management of  IBD with respect to psychosocial issues.
The most striking observation arising from this re-
view was that as many as 10 out of  13 guidelines provid-
ed comments on the psychosocial issues demonstrating 
the recognition of  their importance in IBD management. 
However, the published guidelines differed in the inclu-
sion of  psychosocial topics, particularly between Asia/
Pacific, Europe and the United States, with European 
guidelines more likely to discuss the issue. In the cases 
where psychosocial issues were included in the guide-
lines, the statements and recommendations were similar 
between the countries. ECCO[16,24], Dutch[23] and German 
guidelines[20,26] made the most extensive statements and 
recommendations on psychosocial issues. In contrast, 
three guidelines[15,21,22] did not include any statements or 
recommendations on psychosocial issues. Seven guide-
lines included patient representatives[15,17,18,20,21,26]. How-
ever, the composition of  the guidelines group (i.e., types 
of  professionals involved and/or inclusion of  patients) 
did not affect the role of  psychosocial issues in the guide-
line. Importantly, only six guidelines included comments 
regarding mental health specialists[15,16,20,23,24,26].
The major statements and recommendations on 
psychosocial issues were as follows: (1) psychosocial fac-
tors such as mental disorders or stress do not play a role 
in the aetiology of  IBD[15,19,20,23-26]; (2) psychosocial fac-
tors such as mental health disorders or stress may have 
a negative impact on the course of  IBD[15,19,20,23,24,26]; (3) 
physicians should screen IBD-patients for psychologi-
cal distress and the psychological care recommended 
when required[15,19,24,26]; (4) if  indicated, psychosocial care 
(psychotherapy, psychopharmacotherapy) should be of-
fered[15,19,20,23,24,26]; (5) IBD-centres should collaborate with 
mental health specialists[15,19,20,24,26]; and (6) smoking CD-
patients should be advised to quit[17,18,23,26].
The major statements and recommendations included 
in the guidelines were in line with the recent systematic 
reviews demonstrating that the role of  psychological 
distress and personality as predisposing factors for the 
development of  IBD remains controversial. Attempts 
to investigate the role of  psychological factors in IBD 
exhibited rather conflicting results. Among the studies 
concerning the effects of  stress or depression on the 
course of  IBD, the majority suggest that stress worsens 
IBD, the rest produce either negative or inconclusive 
results[29]. Eighteen randomized controlled studies (19 
papers) were included in a review on psychological thera-
pies in IBD. Psychotherapy was found to have minimal 
effect on measures of  anxiety, depression, quality of  life 
and disease progression although showed promise in 
reducing pain, fatigue, relapse rate and hospitalisation, 
and improving medication adherence. It may also be cost 
effective[30]. Smoking remains the most important envi-
ronmental factor in IBD. Active smoking increases the 
risk of  developing CD. Moreover, CD patients who start 
or continue smoking after disease diagnosis are at risk for 
poorer outcomes such as higher therapeutic requirements 
and disease-related complications, as compared to those 
patients who quit smoking or who never smoked[31].
Psychosocial issues are discussed in the majority 
(10/13) of  recently published evidence-based guidelines, 
supporting their important role in IBD management. 
There is a need for interdisciplinary evidence-based 
guidelines in Asia and the United States to provide spe-
Table 9  German guideline statements and recommendations on psychosocial issues in the management of Crohn’s disease[26]
1 Mental health disorders are the sequelae rather than the cause of CD. Psychological distress is correlated with disease activity and has an impact on 
health-related quality of life and course of the disease (EL2)
2 Psychosocial factors (personality traits, adverse life events, daily hassles) do not contribute to the etiology of CD (EL4)
3 Depression, anxiety and perceived stress are risk factors for flares. It is not certain whether acute adverse life events trigger flares (EL3). Most patients 
believe that stress has an impact on the disease (EL4)
4 The psychosocial consequences and health- related quality of life of patients (accounting for gender differences) should be taken into account in clinical 
practice at regular visits (EL5)
5 Physcians should assess the psychosocial status of patients and their need for psychotherapy. If indicated, psychotherapy should be provided. IBD-
centers should provide an integrated psychosomatic care EL2)
6 Patients should be informed on the existence of patient organisations and selfhelp groups (EL5)
7 Psychotherapy is indicated in the case of mental health disorders such as anxiety and depression, reduced health-related quality of life with 
psychological distress and maladaptive coping (EL2)
8 The choice of a psychotherapeutic method depends on the psychological disturbance and should best be made by a psychotherapist. The choice of 
psychopharmacotherapy should be at the discretion of a psychiatrist specialist in the case of comorbid mental health disorders (e.g., depression and 
anxiety) (EL5)
9 The increased risk of a mental health disorder is associated with an early manifestation of the disease. If needed, psychosocial support should be 
offered to the patient and their families (EL5)
10 Patients using tobacco products should be encouraged to quit smoking (EL2)
CD: Crohn’s disease; EL: Evidence level.
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cific recommendations on the aetiology and manage-
ment of  psychosocial issues in IBD. Patients and mental 
health specialists should be able to participate in guideline 
groups to contribute perspectives on psychosocial issues 
to the guidelines. 
There is strong evidence on co-morbidity of  IBD 
with mental disorders which have been shown to impact 
the disease course. Future guidelines should acknowledge 
the presence of  psychosocial problems in IBD-patients 
and encourage screening for psychological distress. The 
best treatment of  psychosocial problems of  IBD-patients 
is yet to be determined.
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